Terms: = Skin cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Prognosis
15 results:
1. The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis.
Colasanti T; Stefanantoni K; Fantini C; Corinaldesi C; Vasile M; Marampon F; Di Luigi L; Antinozzi C; Sgrò P; Lenzi A; Riccieri V; Crescioli C
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077548
[TBL] [Abstract] [Full Text] [Related]
2. [Predictive value of sentinel lymph node biopsy in prognosis of acral melanoma].
Liu WF; Yang FJ; Niu XH; Sun Y; Huang Z; Jin T; Li Y; Ding Y; Yang F; Chen T
Zhonghua Zhong Liu Za Zhi; 2021 Jan; 43(1):147-154. PubMed ID: 33472329
[No Abstract] [Full Text] [Related]
3. AFF4 facilitates melanoma cell progression by regulating c-jun activity.
Hu H; Zhang Y; Zhao L; Zhao W; Wang X; Ye E; Dong Y; Zhang L; Ran F; Zhou Y; Huang Y
Exp Cell Res; 2021 Feb; 399(2):112445. PubMed ID: 33417923
[TBL] [Abstract] [Full Text] [Related]
4. Androgen Signaling in the Tumor Microenvironment.
Özdemir BC
Adv Exp Med Biol; 2021; 1270():169-183. PubMed ID: 33123999
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
Thakur R; Laye JP; Lauss M; Diaz JMS; O'Shea SJ; Poźniak J; Filia A; Harland M; Gascoyne J; Randerson-Moor JA; Chan M; Mell T; Jönsson G; Bishop DT; Newton-Bishop J; Barrett JH; Nsengimana J
Clin Cancer Res; 2019 Dec; 25(24):7424-7435. PubMed ID: 31515461
[TBL] [Abstract] [Full Text] [Related]
6. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
Zhou S; Liang Y; Zhang X; Liao L; Yang Y; Ouyang W; Xu H
J Invest Dermatol; 2020 Feb; 140(2):395-403.e6. PubMed ID: 31401046
[TBL] [Abstract] [Full Text] [Related]
7. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
[TBL] [Abstract] [Full Text] [Related]
8. C-jun expression in lichen planus, psoriasis, and cutaneous squamous cell carcinoma, an immunohistochemical study.
Abdou AG; Marae AH; Shoeib M; Dawood G; Abouelfath E
J Immunoassay Immunochem; 2018; 39(1):58-69. PubMed ID: 29144206
[TBL] [Abstract] [Full Text] [Related]
9. Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C.
Lal G; Contreras PG; Kulak M; Woodfield G; Bair T; Domann FE; Weigel RJ
PLoS One; 2013; 8(9):e73953. PubMed ID: 24023917
[TBL] [Abstract] [Full Text] [Related]
10. Signal transduction in human cutaneous melanoma and target drugs.
Uzdensky AB; Demyanenko SV; Bibov MY
Curr Cancer Drug Targets; 2013 Oct; 13(8):843-66. PubMed ID: 23675881
[TBL] [Abstract] [Full Text] [Related]
11. Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.
Sun Y; Li H
Protein Cell; 2013 Feb; 4(2):103-16. PubMed ID: 23136067
[TBL] [Abstract] [Full Text] [Related]
12. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.
Ambrosini G; Pratilas CA; Qin LX; Tadi M; Surriga O; Carvajal RD; Schwartz GK
Clin Cancer Res; 2012 Jul; 18(13):3552-61. PubMed ID: 22550165
[TBL] [Abstract] [Full Text] [Related]
13. The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma.
Tentori L; Dorio AS; Mazzon E; Muzi A; Sau A; Cuzzocrea S; Vernole P; Federici G; Caccuri AM; Graziani G
Eur J Cancer; 2011 May; 47(8):1219-30. PubMed ID: 21269821
[TBL] [Abstract] [Full Text] [Related]
14. Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction.
Lewis TB; Robison JE; Bastien R; Milash B; Boucher K; Samlowski WE; Leachman SA; Dirk Noyes R; Wittwer CT; Perreard L; Bernard PS
Cancer; 2005 Oct; 104(8):1678-86. PubMed ID: 16116595
[TBL] [Abstract] [Full Text] [Related]
15. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract] [Full Text] [Related]
